{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:27:00Z","timestamp":1765546020102},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Ther Perspect"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s40267-015-0227-8","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T14:48:16Z","timestamp":1436539696000},"page":"316-322","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Community pharmacists\u2019 attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study"],"prefix":"10.1007","volume":"31","author":[{"given":"Maria","family":"Duarte","sequence":"first","affiliation":[]},{"given":"Paula","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Afonso","family":"Cavaco","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"227_CR1","unstructured":"Guideline on good pharmacovigilance practices (GVP) module V: risk management systems (Rev 1). London: European Medicines Agency and Heads of Medicines Agencies; 2014."},{"issue":"8","key":"227_CR2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00228-008-0475-9","volume":"64","author":"L Harmark","year":"2008","unstructured":"Harmark L, van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):743\u201352.","journal-title":"Eur J Clin Pharmacol."},{"issue":"2","key":"227_CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00228-012-1321-7","volume":"69","author":"C Biagi","year":"2013","unstructured":"Biagi C, Montanaro N, Buccellato E, et al. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). Eur J Clin Pharmacol. 2013;69(2):237\u201344.","journal-title":"Eur J Clin Pharmacol."},{"issue":"5","key":"227_CR4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00228-008-0603-6","volume":"65","author":"ML Johansson","year":"2009","unstructured":"Johansson ML, Brunlof G, Edward C, et al. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009;65(5):511\u20134.","journal-title":"Eur J Clin Pharmacol."},{"issue":"3","key":"227_CR5","first-page":"221","volume":"35","author":"I Oosterhuis","year":"2012","unstructured":"Oosterhuis I, van Hunsel FP, van Puijenbroek EP. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug Saf. 2012;35(3):221\u201332.","journal-title":"Drug Saf."},{"issue":"2","key":"227_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40264-012-0014-6","volume":"36","author":"SN Pal","year":"2013","unstructured":"Pal SN, Duncombe C, Falzon D, et al. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36(2):75\u201381.","journal-title":"Drug Saf."},{"issue":"1","key":"227_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00228-008-0564-9","volume":"65","author":"E Ekman","year":"2009","unstructured":"Ekman E, Backstrom M. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol. 2009;65(1):43\u20136.","journal-title":"Eur J Clin Pharmacol."},{"issue":"12","key":"227_CR8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/pds.3333","volume":"21","author":"MN Paludetto","year":"2012","unstructured":"Paludetto MN, Olivier-Abbal P, Montastruc JL. Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? Pharmacoepidemiol Drug Saf. 2012;21(12):1289\u201394.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"11","key":"227_CR9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/pds.1248","volume":"15","author":"P Olivier","year":"2006","unstructured":"Olivier P, Montastruc JL. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf. 2006;15(11):808\u201312.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"4","key":"227_CR10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1590\/S0102-311X1998000400014","volume":"14","author":"AM Correa-Nunes","year":"1998","unstructured":"Correa-Nunes AM. The pharmacovigilance system in Portugal (its establishment and development) [in Portuguese]. Cad Saude Publica. 1998;14(4):725\u201333.","journal-title":"Cad Saude Publica."},{"issue":"4","key":"227_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.20344\/amp.67","volume":"25","author":"MT Herdeiro","year":"2012","unstructured":"Herdeiro MT, Ferreira M, Ribeiro-Vaz I, et al. The Portuguese pharmacovigilance system [in Portuguese]. Acta Med Port. 2012;25(4):241\u20139.","journal-title":"Acta Med Port."},{"key":"227_CR12","unstructured":"Decree Law N.128\/2013, of 5 September 2013, relating to medicinal products for human use: compiled pharmaceutical legislation. Lisbon: INFARMED; 2013."},{"key":"227_CR13","unstructured":"Alves C, Craveiro N, Batel-Marques F. Boletim do CIM:O Papel do Farmac\u00eautico na Farmacovigil\u00e2ncia. Revista OF. 2010:87\u20138."},{"key":"227_CR14","unstructured":"Relat\u00f3rio anual 2012: Notifica\u00e7\u00f5es e Casos de RAM espont\u00e2neos recebidos no SNF (Sistema Nacional de Farmacovigil\u00e2ncia). Lisbon: INFARMED; 2012."},{"issue":"5","key":"227_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf."},{"issue":"5","key":"227_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11096-012-9675-6","volume":"34","author":"SI Santos Pernas dos","year":"2012","unstructured":"dos Santos Pernas SI, Herdeiro MT, Lopez-Gonzalez E, et al. Attitudes of Portuguese health professionals toward adverse drug reaction reporting. Int J Clin Pharm. 2012;34(5):693\u20138.","journal-title":"Int J Clin Pharm."},{"issue":"4","key":"227_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2753.2001.00295.x","volume":"7","author":"A Figueiras","year":"2001","unstructured":"Figueiras A, Tato F, Fontainas J, et al. Physicians\u2019 attitudes towards voluntary reporting of adverse drug events. J Eval Clin Pract. 2001;7(4):347\u201354.","journal-title":"J Eval Clin Pract."},{"issue":"4","key":"227_CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2753.2003.00456.x","volume":"10","author":"MT Herdeiro","year":"2004","unstructured":"Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract. 2004;10(4):483\u20139.","journal-title":"J Eval Clin Pract."},{"issue":"1","key":"227_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2125.1997.00616.x","volume":"44","author":"P McGettigan","year":"1997","unstructured":"McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997;44(1):98\u2013100.","journal-title":"Br J Clin Pharmacol."},{"key":"227_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2050-6511-14-16","volume":"14","author":"KC Santosh","year":"2013","unstructured":"Santosh KC, Tragulpiankit P, Gorsanan S, et al. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14:16.","journal-title":"BMC Pharmacol Toxicol."},{"issue":"6","key":"227_CR21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2125.2005.02504.x","volume":"60","author":"A Vallano","year":"2005","unstructured":"Vallano A, Cereza G, Pedros C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653\u20138.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"227_CR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2125.1999.00060.x","volume":"48","author":"IA Eland","year":"1999","unstructured":"Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623\u20137.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"227_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pds.1298","volume":"16","author":"AG Granas","year":"2007","unstructured":"Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists\u2019 attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16(4):429\u201334.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"227_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.2042-7174.1999.tb00955.x","volume":"7","author":"CF Green","year":"1999","unstructured":"Green CF, Mottram DR, Raval D, et al. Community pharmacists\u2019 attitudes to adverse drug reaction reporting. Int J Pharm Pract. 1999;7(2):92\u20139.","journal-title":"Int J Pharm Pract."},{"issue":"1","key":"227_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2125.2001.01306.x","volume":"51","author":"CF Green","year":"2001","unstructured":"Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81\u20136.","journal-title":"Br J Clin Pharmacol."},{"issue":"4","key":"227_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00002018-200629040-00004","volume":"29","author":"MT Herdeiro","year":"2006","unstructured":"Herdeiro MT, Figueiras A, Polonia J, et al. Influence of pharmacists\u2019 attitudes on adverse drug reaction reporting : a case-control study in Portugal. Drug Saf. 2006;29(4):331\u201340.","journal-title":"Drug Saf."},{"issue":"11","key":"227_CR27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","volume":"30","author":"M Irujo","year":"2007","unstructured":"Irujo M, Beitia G, Bes-Rastrollo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073\u201382.","journal-title":"Drug Saf."},{"key":"227_CR28","doi-asserted-by":"crossref","unstructured":"Mes K, de Jong-van den Berg LTW, Van Grootheest AC. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pract. 2002;10(4):267\u201372.","DOI":"10.1211\/096176702776868460"},{"issue":"3","key":"227_CR29","first-page":"181","volume":"1","author":"M Zolezzi","year":"2005","unstructured":"Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: implications for pharmacists. Ther Clin Risk Manag. 2005;1(3):181\u20138.","journal-title":"Ther Clin Risk Manag."},{"issue":"1","key":"227_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2011.03944.x","volume":"72","author":"P Gavaza","year":"2011","unstructured":"Gavaza P, Brown CM, Lawson KA, et al. Influence of attitudes on pharmacists\u2019 intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol. 2011;72(1):143\u201352.","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"227_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pds.1792","volume":"19","author":"C Su","year":"2010","unstructured":"Su C, Ji H, Su Y. Hospital pharmacists\u2019 knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemiol Drug Saf. 2010;19(3):217\u201322.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"227_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PTS.0000000000000051","volume":"10","author":"RM Elkalmi","year":"2014","unstructured":"Elkalmi RM, Hassali MA, Ibrahim MI, et al. Community pharmacists\u2019 attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight. J Patient Saf. 2014;10(2):81\u20137.","journal-title":"J Patient Saf."},{"key":"227_CR33","unstructured":"Relat\u00f3rio anual 2012: notifica\u00e7\u00f5es e casos de RAM espont\u00e2neos recebidos no SNF (Sistema Nacional de Farmacovigil\u00e2ncia). Lisbon: INFARMED; 2012."},{"key":"227_CR34","unstructured":"Relat\u00f3rio anual 2013: notifica\u00e7\u00f5es e casos de RAM espont\u00e2neos recebidos no SNF (Sistema Nacional de Farmacovigil\u00e2ncia). Lisbon: INFARMED; 2013."},{"key":"227_CR35","unstructured":"Sistema Nacional de Farmacovigil\u00e2ncia (SNF): notifica\u00e7\u00f5es e casos de RAM\u20141\u00baT\/2014. Lisbon: INFARMED; 2014."},{"key":"227_CR36","unstructured":"Sistema Nacional de Farmacovigil\u00e2ncia (SNF): notifica\u00e7\u00f5es e casos de RAM\u20142\u00baT\/2014. Lisbon: INFARMED; 2014."},{"key":"227_CR37","unstructured":"Sistema Nacional de Farmacovigil\u00e2ncia (SNF): notifica\u00e7\u00f5es e casos de RAM\u20143\u00baT\/2014. Lisbon: INFARMED; 2014."},{"key":"227_CR38","unstructured":"Cabrita J, Soares M, Martins S. Relat\u00f3rio final da An\u00e1lise da base de dados do Sistema Nacional de Farmacovigil\u00e2ncia (SVIG) 2009\u20132011. Lisbon: INFARMED; 2012."},{"issue":"Suppl 1","key":"227_CR39","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.4103\/0976-500X.120940","volume":"4","author":"G Pimpinella","year":"2013","unstructured":"Pimpinella G, Tartaglia L. Pharmacovigilance and the Italian Medicines Agency. J Pharmacol Pharmacotherap. 2013;4(Suppl 1):S4\u20136.","journal-title":"J Pharmacol Pharmacotherap."},{"key":"227_CR40","unstructured":"Regulamento de Execu\u00e7\u00e3o (UE) N\u00ba. 520\/2012.19 de Junho de 2012 Lisbon: INFARMED; 2012."},{"key":"227_CR41","unstructured":"Directive 2010\/84\/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance: directive 2001\/83\/EC on the Community code relating to medicinal products for human use. OJEU; 2010."},{"issue":"6","key":"227_CR42","first-page":"590","volume":"26","author":"E Paulino","year":"2010","unstructured":"Paulino E, Guerreiro M, Cantrill J, et al. Community pharmacists and physicians inter-professional work: insights from qualitative studies with multiple stakeholders. Rev Port Clin Geral. 2010;26(6):590\u2013606.","journal-title":"Rev Port Clin Geral."},{"key":"227_CR43","volume-title":"Psicologia social","year":"2013","unstructured":"Vala J, Monterio MB, editors. Psicologia social. 9th ed. Lisbon: Funda\u00e7\u00e3o Calouste Gulbenkian; 2013.","edition":"9"},{"issue":"2","key":"227_CR44","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11096-013-9882-9","volume":"36","author":"AM Cavaco","year":"2014","unstructured":"Cavaco AM, Krookas AA. Community pharmacies automation: any impact on counselling duration and job satisfaction? Int J Clin Pharm. 2014;36(2):325\u201335.","journal-title":"Int J Clin Pharm."},{"key":"227_CR45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-642-36981-0_40","volume-title":"Advances in information systems and technologies, AISC 206","author":"L Lap\u00e3o","year":"2013","unstructured":"Lap\u00e3o L, Greg\u00f3rio J, Cavaco A, et al. Implementing eHealth Services for enhanced pharmaceutical care provision: opportunities and challenges. In: Rocha A, et al., editors. Advances in information systems and technologies, AISC 206. Berlin Heidelberg: Springer; 2013. p. 433\u201343."},{"key":"227_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/CLEP.S4775","volume":"1","author":"M Molokhia","year":"2009","unstructured":"Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clin Epidemiol. 2009;1:75\u201392.","journal-title":"Clin Epidemiol."},{"key":"227_CR47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1471-2458-9-274","volume":"9","author":"M Tabali","year":"2009","unstructured":"Tabali M, Jeschke E, Bockelbrink A, et al. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009;9:274.","journal-title":"BMC Public Health."},{"issue":"1","key":"227_CR48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0034-89102010005000050","volume":"45","author":"I Ribeiro-Vaz","year":"2011","unstructured":"Ribeiro-Vaz I, Herdeiro MT, Polonia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45(1):129\u201335.","journal-title":"Rev Saude Publica."},{"issue":"5","key":"227_CR49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5688\/ajpe75596","volume":"75","author":"RM Elkalmi","year":"2011","unstructured":"Elkalmi RM, Hassali MA, Ibrahim MI, et al. Pharmacy students\u2019 knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5):96.","journal-title":"Am J Pharm Educ."},{"issue":"3","key":"227_CR50","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pds.3311","volume":"22","author":"MP Smith","year":"2013","unstructured":"Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiol Drug Saf. 2013;22(3):223\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"227_CR51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1472-6963-13-313","volume":"13","author":"A Parrella","year":"2013","unstructured":"Parrella A, Braunack-Mayer A, Gold M, et al. Healthcare providers\u2019 knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Serv Res. 2013;13:313.","journal-title":"BMC Health Serv Res."},{"key":"227_CR52","doi-asserted-by":"crossref","first-page":"e000367","DOI":"10.1136\/bmjopen-2011-000367","volume":"2","author":"H Khalili","year":"2012","unstructured":"Khalili H, Mohebbi N, Hendoiee N, et al. Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre- and post-clinical pharmacists\u2019 interventional study. BMJ Open. 2012;2:e000367.","journal-title":"BMJ Open."}],"container-title":["Drugs & Therapy Perspectives"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-015-0227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40267-015-0227-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40267-015-0227-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T04:46:27Z","timestamp":1691815587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40267-015-0227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1007\/s40267-015-0227-8","relation":{},"ISSN":["1172-0360","1179-1977"],"issn-type":[{"value":"1172-0360","type":"print"},{"value":"1179-1977","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}